Single Stage Direct-to-Implant Breast Reconstruction Has Lower Complication Rates Than Tissue Expander and Implant and Comparable Rates to Autologous Reconstruction in Patients Receiving Postmastectomy Radiation

医学 乳房再造术 包膜挛缩 植入 外科 累积发病率 阶段(地层学) 并发症 放射治疗 入射(几何) 乳房切除术 脂肪坏死 乳腺癌 移植 内科学 癌症 物理 古生物学 光学 生物
作者
George E. Naoum,Laura Salama,Andrzej Niemierko,Bruno Lavajo Vieira,Yazid Belkacémi,Amy S. Colwell,Jonathan M. Winograd,Barbara L. Smith,Alice Y. Ho,Alphonse G. Taghian
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier BV]
卷期号:106 (3): 514-524 被引量:88
标识
DOI:10.1016/j.ijrobp.2019.11.008
摘要

Purpose To compare single-stage direct-to-implant (DTI) immediate reconstruction to the commonly used 2-stages expander and implant (TE/I) or autologous reconstruction with focus on postmastectomy radiation therapy (PMRT) setting. Methods and Materials We reviewed the charts of 1,286 patients who underwent 1,814 breast reconstructions at our institution with and without PMRT from 1997 to 2017. Patients were divided into 6 groups according to type of reconstruction and PMRT status. Primary objective was reconstruction complications defined solely on surgical reintervention operative notes such as infection, skin necrosis, and fat necrosis across all groups. Implant-related complications such as capsular contracture, implant rupture or exposure, or implant failure were compared between TE/I and DTI. Kaplan–Meier estimates were used to calculate 5-year cumulative incidence of complications. The secondary objective was to compare the 3 reconstruction types in settings of immediate reconstruction followed by PMRT on multivariable analysis. Results Median follow-up was 5.8 years. Among 1286 patients, 41.1% (N = 529/1286) received PMRT. Among 1814 reconstructed breasts, autologous, single-stage, and TE/I represented 18.7%, 34.8%, and 46.2%, respectively. With no PMRT, the 5-year cumulative incidence of any reconstruction complication was 11.1%, 12.6%, and 19.5% for autologous, DTI, and TE/I reconstructions, respectively. The addition of PMRT resulted in 5-year cumulative incidence of 15.1%, 18.2%, and 36.8%, respectively. The multivariable analysis showed that DTI was associated with lesser complications compared with TE/I, whereas no significant difference was noted between DTI and autologous. Conclusions Single-stage DTI reconstruction had significantly lower complication rates than TE/I with and without PMRT. Single-stage complication rates were not significantly different from autologous complication rates in PMRT settings. Single-stage reconstruction may offer a valuable option for patients receiving PMRT. To compare single-stage direct-to-implant (DTI) immediate reconstruction to the commonly used 2-stages expander and implant (TE/I) or autologous reconstruction with focus on postmastectomy radiation therapy (PMRT) setting. We reviewed the charts of 1,286 patients who underwent 1,814 breast reconstructions at our institution with and without PMRT from 1997 to 2017. Patients were divided into 6 groups according to type of reconstruction and PMRT status. Primary objective was reconstruction complications defined solely on surgical reintervention operative notes such as infection, skin necrosis, and fat necrosis across all groups. Implant-related complications such as capsular contracture, implant rupture or exposure, or implant failure were compared between TE/I and DTI. Kaplan–Meier estimates were used to calculate 5-year cumulative incidence of complications. The secondary objective was to compare the 3 reconstruction types in settings of immediate reconstruction followed by PMRT on multivariable analysis. Median follow-up was 5.8 years. Among 1286 patients, 41.1% (N = 529/1286) received PMRT. Among 1814 reconstructed breasts, autologous, single-stage, and TE/I represented 18.7%, 34.8%, and 46.2%, respectively. With no PMRT, the 5-year cumulative incidence of any reconstruction complication was 11.1%, 12.6%, and 19.5% for autologous, DTI, and TE/I reconstructions, respectively. The addition of PMRT resulted in 5-year cumulative incidence of 15.1%, 18.2%, and 36.8%, respectively. The multivariable analysis showed that DTI was associated with lesser complications compared with TE/I, whereas no significant difference was noted between DTI and autologous. Single-stage DTI reconstruction had significantly lower complication rates than TE/I with and without PMRT. Single-stage complication rates were not significantly different from autologous complication rates in PMRT settings. Single-stage reconstruction may offer a valuable option for patients receiving PMRT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李健应助D515采纳,获得30
1秒前
天天快乐应助stacy采纳,获得10
1秒前
天外来物完成签到 ,获得积分20
1秒前
爆米花应助山野的雾采纳,获得10
2秒前
2秒前
在水一方应助666采纳,获得30
4秒前
碧蓝大炮完成签到,获得积分10
4秒前
怀抱2781完成签到 ,获得积分10
4秒前
顾矜应助陈冠羽采纳,获得10
4秒前
5秒前
阿瑜完成签到,获得积分10
5秒前
旦堡应助笨小孩采纳,获得10
5秒前
豆豆浆发布了新的文献求助10
6秒前
豆子完成签到,获得积分10
7秒前
传奇3应助汪思显采纳,获得10
7秒前
科研通AI2S应助Lycoris林曦采纳,获得10
8秒前
心软的神发布了新的文献求助30
8秒前
momo完成签到,获得积分10
9秒前
TDL完成签到,获得积分10
9秒前
guanghan完成签到,获得积分10
9秒前
9秒前
9秒前
拼搏的雨泽完成签到,获得积分10
10秒前
怀抱2781关注了科研通微信公众号
11秒前
小华完成签到,获得积分10
11秒前
12秒前
nonopanda发布了新的文献求助10
12秒前
Lucas应助无奈的函采纳,获得10
12秒前
molihuakai应助豆豆浆采纳,获得10
13秒前
充电宝应助任性的牛排采纳,获得50
13秒前
13秒前
山野的雾发布了新的文献求助10
14秒前
李纪龙完成签到,获得积分10
14秒前
淡淡念桃完成签到,获得积分10
14秒前
samgood完成签到,获得积分20
15秒前
132完成签到,获得积分10
15秒前
15秒前
香蕉觅云应助科研通管家采纳,获得10
16秒前
慕青应助科研通管家采纳,获得10
16秒前
CipherSage应助科研通管家采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
HYDROLYSE ACIDE DE QUELQUES DIOXASPIROCYCLANES 1000
Navigating Normative Orders. Interdisciplinary Perspectives 800
1 Peter and Christ's Descent to the Dead in Its Early Christian Reception 700
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 600
Organizational Behavior 510
Management and the Arts 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7740792
求助须知:如何正确求助?哪些是违规求助? 9289359
关于积分的说明 20195369
捐赠科研通 7318948
什么是DOI,文献DOI怎么找? 3306533
关于科研通互助平台的介绍 2458816
邀请新用户注册赠送积分活动 2316786